365
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set

ORCID Icon, , , , ORCID Icon, , , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1243-1246 | Received 25 Nov 2020, Accepted 09 Dec 2020, Published online: 13 Jan 2021
 

Acknowledgements

The authors acknowledge all the medical, nursing and pharmacy staff for their contributions in managing these patients.

Authorship contributions

MZ and RP designed the study; MZ, GL, DD, RP analyzed the data; MZ and RP wrote the manuscript; SC, CK, SM, XP, NR, SS, JS, AW, KW contributed data, critically appraised and approved the final manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This data was in part supported by an unrestricted grant from Takeda. RP is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.